SIGA Posts Q1 Loss, But Management Flags Q2 Recovery on International and U.S. Orders
Read source articleWhat happened
SIGA Technologies reported a first-quarter loss as product deliveries remained minimal, consistent with the lumpy revenue pattern typical of its single-product, government-contract-driven business. Management stated on the earnings call that it expects a pickup in the second quarter, driven by an international order and additional deliveries to the U.S. Strategic National Stockpile. This forecast aligns with the company's historical volatility, where revenue is concentrated in large, episodic stockpile purchases rather than steady commercial demand. The DeepValue report highlighted SIGA as a potential buy at ~5.5x trailing EPS, with a net cash balance sheet and a DCF-based value ~30% above the current price, but cautioned that the thesis hinges on future BARDA contracting and policy risk. The Q1 loss does not alter the fundamental narrative of a contract-dependent annuity; instead, it reinforces the need for clear visibility on post-19C contract renewals to sustain the valuation.
Implication
The Q1 loss was widely anticipated given the contract timing, and management's guidance for a Q2 recovery offers near-term support for cash flow and the special dividend program. However, the investment case remains contingent on BARDA exercising remaining options and securing a successor contract beyond the current 19C arrangement, as the company's single-asset, single-customer concentration makes it vulnerable to policy shifts. The negative mpox efficacy data and Tembexa competition further cloud the long-term revenue outlook. Risk-tolerant investors may find the current valuation attractive, but more conservative investors should wait for clearer signs of recurring government demand.
Thesis delta
The Q1 loss and anticipated Q2 rebound are consistent with the lumpy revenue pattern already embedded in the thesis, and do not alter our view. The key catalysts remain BARDA's decisions on contract renewal and international sales traction, which are unchanged by this earnings report.
Confidence
Medium